(Alliance News) - Stock prices in London opened mixed on Friday, after a strong run this week, while investors wait to see how major US banks fared in the second quarter of the year. Read More
(Alliance News) - Stocks in London are expected to slip into the red at Friday's open, in a tepid conclusion to what has been a largely positive week for global equities, as the market prices in a lower peak for US interest rates. Read More
(Alliance News) - Daiichi Sankyo Co Ltd on Wednesday its metastatic breast cancer treatment with AstraZeneca PLC was approved in China as a monotherapy for adult patients. Read More
(Alliance News) - Stock prices in Europe diverged on Friday, with the FTSE 100 underperforming, as a weaker-than-expected US jobs report did little for equities amid the expectation that the Federal is not done with hiking. Read More
(Alliance News) - Stocks in London were largely higher on Tuesday, though the FTSE 100 slipped into the red amid weakness, while US markets were shut for the independence day holiday. Read More
(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted. Read More
(Alliance News) - AstraZeneca PLC on Monday saw shares fall, as test results suggested a new lung cancer drug may be less successful than hoped, despite being generally positive. Read More
(Alliance News) - London's FTSE 100 ran out of steam on Monday to close little changed, while New York markets made a muted start to an abbreviated session ahead of Independence Day. Read More
(Alliance News) - European equities went into Monday afternoon on the up, with the FTSE 100 outperforming as it was supported by its natural resources sector and oil majors. Read More
(Alliance News) - European markets rose at Monday's open, kicking off the start of the second half on a positive note, boosted by strong trading in Asia and New York, Read More
(Alliance News) - AstraZeneca PLC and Tokyo-based partner Daiichi Sankyo Co Ltd on Monday announced that their investigational antibody drug conjugate Datopotamab deruxtecan showed positive results in an advanced non-small cell lung cancer trial. Read More
AstraZeneca PLC - Cambridge-based pharmaceutical company - Announces USD400 million investment in global AZ Forest programme, aiming to plant 50 million trees by the end of 2025 and 200 million trees by 2030. Projects are in Brazil, India, Vietnam, Ghana and Rwanda. The programme is focused on reforestation, biodiversity and community resilience and spans over 100,000 hectares worldwide. Read More
(Alliance News) - AstraZeneca PLC on Monday said Soliris has been recommended for marketing authorisation in the EU for expanded use in generalised myasthenia gravis, gMG. Read More
